220 E FIRST ST, BETHLEHEM, PA
Other Events
Stockholders Approve Amendment to 2000 Stock Award Plan - 5M Shares Added
Announces First Quarter 2026 Financial Results
Appoints John D. Bertrand to its Board of Directors
Investor Presentation
Director Resignation - David J. Shulkin Steps Down from Board
Announces Fourth Quarter 2025 Financial Results
Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review
FY 2025
Q3
Q2
Q1
FY 2024
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities Offered under a Shelf Registration
PRE 14A
Additional Proxy Materials
Definitive Additional Information Statement
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload